The pharmacy is now in our new location at 22629 Twain Harte Drive, Suite D, Twain Harte, CA 95383!
Download our NEW mobile app!
Please be advised the pharmacy hours have changed on Fridays & Saturdays:
Friday - 9am to 6pm (Closed 1pm to 2pm for Lunch)
Saturday - Closed
Patient Resources
Get Healthy!
Results for search "Prescription Drugs".
Health News Results - 221
Most U.S. Seniors Prescribed at Least 1 Drug, But Many Skip Meds Due to Cost
- Ernie Mundell HealthDay Reporter
- September 5, 2024
- Full Page
Too many U.S. seniors are skipping their prescription meds due to cost, and the problem is most acute among the poor and chronically ill, new data shows.
Almost all (88.6%) Americans age 65 or older have been prescribed at least one prescription medicine, according to 20...
New Deals Will Cut Medicare Costs for Expensive Drugs
- Robin Foster HealthDay Reporter
- August 15, 2024
- Full Page
The Biden administration said Thursday that it has signed deals with drug companies that will lower the prices on 10 of the most popular and expensive drugs used by American seniors.
Taxpayers should save $6 billion because of the new prices, while seniors using Medicare...
How Common Drugs, Lotions Can Worsen Sunlight's Harm to Your Skin
- Robin Foster HealthDay Reporter
- August 10, 2024
- Full Page
Most folks know that a good sunscreen can guard against the sun's harmful rays, but many might not realize that some medications and creams can undo some of that protection.
“There are multiple reasons we should be mindful of excessive sun exposure aside from skin ...
Summer's Heat Can Damage Your Medicines: Keep Them Safe
- Robin Foster HealthDay Reporter
- July 27, 2024
- Full Page
As scorching temperatures continue to plague the United States this summer, millions of Americans are at risk for dehydration and heat-linked illness.
But what about their medications? Can rising temperatures render those useless and leave patients vulnerable?
Yes...
Big Drop in U.S. Kids, Teens Misusing Prescription Meds
- Dennis Thompson HealthDay Reporter
- July 24, 2024
- Full Page
Misuse of illicit prescription drugs is falling dramatically among U.S. high school students, a new study says.
The percentage of seniors who say they’ve misused prescri...
New Drug Tames Stress Incontinence in Clinical Trial
- Dennis Thompson HealthDay Reporter
- July 15, 2024
- Full Page
An experimental drug appears to help women deal with stress incontinence, clinical trial data show.
The drug, for now dubbed TAS-303, reduced the frequency of leaks related to stress incontinence by about 58%, compared with 47% reduction in a placebo group, trial results...
FDA Approves New Drug to Treat Alzheimer's
- Robin Foster HealthDay Reporter
- July 2, 2024
- Full Page
A new drug to treat Alzheimer's disease was approved by the U.S. Food and Drug Administration on Tuesday.
In clinical trials, donanemab (Kisunla) modestly slo...
Medicare Warnings Stop Nursing Homes From Overusing Antipsychotic Meds
- Dennis Thompson HealthDay Reporter
- April 26, 2024
- Full Page
Warning letters sent by Medicare officials can prompt a decline in antipsychotic prescriptions for seniors with dementia, a new study finds.
Letters sent to heavy prescribers of quetiapine (Seroquel), the most popular a...
Dietary Changes May Beat Meds in Treating IBS
- Robin Foster HealthDay Reporter
- April 19, 2024
- Full Page
The right diet may be the best medicine for easing the painful symptoms of irritable bowel syndrome (IBS), new research shows.
In the study, two different eating plans beat standard medications in treating the debilitating symptoms of the gastrointestinal disease. One d...
Weight-loss Drug Zepbound Eases Sleep Apnea in Company Trials
- Robin Foster HealthDay Reporter
- April 17, 2024
- Full Page
Zepbound, one of the wildly popular weight-loss drugs that millions of Americans now take, eased sleep apnea in obese adults in two company trials, drug maker Eli Lilly announced Wednesday.
Mouse Study Shows Microplastics Migrating From Gut to Other Organs
- Dennis Thompson HealthDay Reporter
- April 17, 2024
- Full Page
Microplastics could be migrating from the digestive tract into the kidneys, livers and brains of human beings, a new mouse study suggests.
Lab mice exposed to microplastics in their drinking water wound up with the tiny plastic particles lodged in a number of different o...
Poor Trial Results May Prompt Maker to Pull ALS Drug From Market
- Robin Foster HealthDay Reporter
- March 11, 2024
- Full Page
Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market.
In a statement...
Cyberattack Stalls Prescription Dispensing at UnitedHealth
- Robin Foster HealthDay Reporter
- February 27, 2024
- Full Page
For nearly a week, prescription drug orders have been disrupted at thousands of pharmacies as the largest health insurer in the United States tries to fully restore services following a cyberattack.
The security breach was first detected last Wednesday at Change Healthc...
Drug That Treats Cocaine Addiction May Curb Colon Cancer
- Dennis Thompson HealthDay Reporter
- February 16, 2024
- Full Page
FRIDAY, Feb. 16, 2024 (HealthDay news) -- A drug first developed to treat cocaine addiction might also help slow the spread of advanced colon cancer, a new study suggests.
The drug vanoxerine appears to suppress cancer stem cell activity by essentially rewiring gene netw...
Drug Used to Treat Rheumatoid Arthritis May Also Help Prevent It
- Dennis Thompson HealthDay Reporter
- February 15, 2024
- Full Page
Philip Day loved playing soccer so much that the 35-year-old software engineer founded a website"FootballMatcher.com"to help people connect for pickup games.
The fun went on pause when Day developed joint pain so bad it kept him from his favorite sport.
"The pain g...
U.S. Prescription Drug Prices Nearly Triple Those of Other Nations
- Dennis Thompson HealthDay Reporter
- February 5, 2024
- Full Page
Americans pay nearly three times as much for their prescription drugs as residents of other nations do, new research shows.
Drug prices in the United States average nearly 2.8 times those seen in 33 other countries, the
FDA to Import Syphilis Drug From France Amid Shortage
- Robin Foster HealthDay Reporter
- January 11, 2024
- Full Page
Amid an ongoing shortage of the first-line treatment for syphilis in the United States, the U.S. Food and Drug Administration will allow the importation of a different syphilis drug from a French drugmaker.
In a letter<...
FDA Gives Florida OK to Import Cheaper Drugs From Canada
- Dennis Thompson HealthDay Reporter
- January 5, 2024
- Full Page
The U.S. Food and Drug Administration on Friday gave the nod to a Florida plan to import drugs from Canada at much lower prices than in the United States.
The approval could prove to be a major turning point for the United States' prescription drug market.
U.S. res...
Resolve to Keep Your Allergies, Asthma in Check in 2024
- Ernie Mundell HealthDay Reporter
- December 18, 2023
- Full Page
If you're one of the 50 million Americans with asthma or allergies, 2024 is another year to redouble efforts to manage them.
But how?
"It's not always easy to get allergies and asthma under control,"allergist
New Weight-Loss Drug Zepbound Is Now Available, Company Says
- Robin Foster HealthDay Reporter
- December 6, 2023
- Full Page
The newly approved weight-loss medication known as Zepbound is now available for patients to take, drug maker Eli Lilly announced Tuesday.
"Today opens another chapter for adults living with obesity who have been looking for a new treatment option like Zepbound," Rhonda ...
Amazon to Test Drones to Deliver Prescriptions to Your Door
- Cara Murez HealthDay Reporter
- October 19, 2023
- Full Page
Soon, you may be able to step out on your front porch and wait for your prescription medication to drop from the sky.
On Wednesday, Amazon Pharmacy announced that it is starting to test speedy prescription drug delivery by drones in selected locations.
"We're taug...
Americans Can Expect to Spend Half Their Lives Taking a Prescription Drug
- Cara Murez HealthDay Reporter
- October 17, 2023
- Full Page
Americans born in recent years can likely count on taking prescription drugs for about half their life, according to new research.
For males born in 2019, it's about 48% of their lives. For women, it's 60% of their lifetime, the study found.
"The years that pe...
Rite Aid Pharmacy Chain Files for Bankruptcy
- Cara Murez HealthDay Reporter
- October 16, 2023
- Full Page
The drugstore chain Rite Aid has filed for Chapter 11 bankruptcy, due largely to competition and thousands of lawsuits for its role in allegedly filling unlawful opioid prescriptions.
The company filed a notice Thursday with the U.S. Securities and Exchange Commission sa...
In Study, Diabetes Drug Mounjaro Helped Dieters Shed an Average of 60 Pounds
- Cara Murez HealthDay Reporter
- October 16, 2023
- Full Page
A new trial demonstrates the power of the diabetes drug Mounjaro in fighting obesity, helping folks who used the medication lose about 60 pounds.
"In this study, people who added tirzepatide [Mounjaro] to diet and exercise saw greater, longer-lasting weight reduction tha...
Wegovy, Ozempic Help Folks Lose Weight, But How?
- Cara Murez HealthDay Reporter
- October 10, 2023
- Full Page
As many doctors and patients hail the advent of weight-loss drugs like Ozempic and Wegovy as the perfect fix for obesity, some experts are urging caution.
The drugs are not well-tolerated by everyone struggling with obesity. For some folks, the weight piles back on as so...
Cancer Drug Shortages Persist Across U.S.
- Cara Murez HealthDay Reporter
- October 5, 2023
- Full Page
U.S. cancer centers continue to have shortages of commonly used chemotherapy drugs, a new survey shows, though the medications are not as scarce as they were last June.
The National Comprehensive Cancer Network (NCCN), a nonprofit alliance of leading cancer centers,
Major Drug Companies Agree to Price Negotiations With U.S. Government
- Cara Murez HealthDay Reporter
- October 3, 2023
- Full Page
Pharmaceutical companies that make the 10 prescription drugs chosen to be the first for price negotiations for Medicare patients have agreed to talks with the government.
The Biden administration announced Tuesday that the drugmakers, including Merck, Bristol Myers Squib...
Despite New Long-Term Options, People Still Prefer Daily PrEP Pill to Prevent HIV
- Cara Murez HealthDay Reporter
- October 3, 2023
- Full Page
New ways to deliver drugs that prevent infection with HIV are out there, but many people still prefer the standard daily PrEP pill, a new study shows.
"The oral pill is very efficacious when people take it every day, and it really has the potential to curb HIV transmiss...
FDA Panel Says No to Experimental ALS Drug
- Cara Murez HealthDay Reporter
- September 28, 2023
- Full Page
An advisory panel to the U.S. Food and Drug Administration on Wednesday voted resoundingly against recommending a stem cell-based experimental treatment for ALS.
Although the FDA isn't bound by the votes of its advisory panels, agency scientists have already penned a sca...
ADHD Drug Errors Among Kids Have Quadrupled in 20 Years
- Cara Murez HealthDay Reporter
- September 18, 2023
- Full Page
Over 3 million American children now take medication for attention-deficit/hyperactivity disorder (ADHD), but new research shows medication errors have spiked nearly 300% in the past two decades for these kids.
The increase in ADHD medication errors parallels the increas...
In Small Study, Ozempic Helped People With Type 1 Diabetes Quit Insulin Treatments
- Amy Norton HealthDay Reporter
- September 7, 2023
- Full Page
The blockbuster drug Ozempic has become a household name for its ability to spur weight loss. Now an early study hints at an intriguing possibility: The drug might allow people newly diagnosed with type 1 diabetes to drop their daily insulin shots.
Experts emphasized tha...
Heart, Diabetes, Cancer Drugs on List for Medicare Price Negotiations, White House Says
- Dennis Thompson HealthDay Reporter
- August 29, 2023
- Full Page
The Biden administration on Tuesday named the first 10 medicines that will be subject to price negotiations between Medicare and participating drug companies.
The list represents the first step in a landmark program aimed at reducing the government's drug spending, and p...
Wegovy May Be Valuable New Option for Heart Failure Patients
- Ernie Mundell HealthDay Reporter
- August 25, 2023
- Full Page
Weight-loss drug Wegovy (semaglutide) and its diabetes-focused cousin, Ozempic, have already upended the treatment of both obesity and diabetes, with sales of both drugs skyrocketing.
Now, injected Wegovy could prove a boon for many patients battling heart failure, a new...
Most Alzheimer's Patients May Be Ineligible for Newly Approved Drugs
- Cara Murez HealthDay Reporter
- August 17, 2023
- Full Page
Two recently approved treatments offer newfound hope for patients in the early stages of Alzheimer's disease, but most people who could benefit will likely be deemed ineligible, a new study finds.
Alzheimer's affects about 6.7 million Americans age 65 and older. Bu...
Amid Shortages, Maker Says Restrictions on Wegovy Will Continue Into 2024
- Cara Murez HealthDay Reporter
- August 11, 2023
- Full Page
As demand for the wildly popular weight-loss drug Wegovy continues to climb, drug maker Novo Nordisk said Thursday that it will continue restrictions on starter doses of the medication into 2024.
The new plan extends by months existing restrictions and means patients who...
After U.S. Warns of Counterfeit Pills Laced With Fentanyl, Mexico Shuts Down 23 Pharmacies
- Cara Murez HealthDay Reporter
- August 9, 2023
- Full Page
Following a four-day raid, Mexico has closed 23 pharmacies in Caribbean resorts of Cancun, Playa del Carmen and Tulum for irregular pill sales.
Amid Shortages, Federal Agencies Ask Drugmakers to Boost Output of ADHD Meds
- Cara Murez HealthDay Reporter
- August 2, 2023
- Full Page
While demand for prescription stimulants is surging, a shortage of the drugs persists, so federal officials have stepped in and asked drug companies to ramp up production of the medications.
Officials from both the U.S. Food and Drug Administration and the U.S. Drug Enfo...
The Earlier MS Is Treated, the Better
- Cara Murez HealthDay Reporter
- July 26, 2023
- Full Page
Patients who get treatment for multiple sclerosis at the earliest signs of disease may have a lower risk of disability later, new research suggests.
Among nearly 600 patients, there were lower odds of disability and progression among people diagnosed and treated within s...
Are These Pricey New Alzheimer's Drugs Worth It?
- Dennis Thompson HealthDay Reporter
- July 24, 2023
- Full Page
Breakthrough new drugs that clear amyloid beta plaques from the brain are shaking up the field of Alzheimer's disease research.
The fact that patients' mental deterioration slows when they're on anti-amyloid drugs is solid proof that abnormal amyloid proteins are one of ...
Major Drug Shortages Not Likely After Tornado Damages Pfizer Plant, FDA says
- Steven Reinberg HealthDay Reporter
- July 24, 2023
- Full Page
Tornado damage to a Pfizer drug-making plant in North Carolina is unlikely to trigger drug shortages across the country, the U.S. Food and Drug Administration says.
"We do not expect there to be any immediate significant impacts on supply, given the products are current...
Risk of Suicidal Thoughts With Popular Weight-Loss Drugs Being Investigated by European Regulators
- Cara Murez HealthDay Reporter
- July 11, 2023
- Full Page
The European Medicines Agency is investigating concerns that popular weight-loss drugs like Ozempic and Saxenda may be linked to suicidal thoughts and thoughts of self-harm.
Three case reports from Iceland spurred the agency's safety committee to conduct a medication re...
In Study, Almost Half of Obese Teens Were No Longer So After Taking Wegovy/Ozempic
- Denise Mann HealthDay Reporter
- July 10, 2023
- Full Page
The drugs Wegovy and Ozempic are all the rage for weight loss these days, and now a new study shows these injections may be game-changers for obese teenagers, too.
This trial, funded by drug maker Novo Nordisk, found that nearly half of all adolescents on sema...
Fewer Kids Are Being Prescribed Antipsychotic Meds
- Cara Murez HealthDay Reporter
- July 7, 2023
- Full Page
The use of antipsychotic medication in children is continuing to plummet, likely because of better policies and education, new research shows.
The study found a 43% drop in antipsychotic prescriptions for Medicaid-enrolled children in 45 states, a stark contrast from the...
New Competitor to Wegovy Shows Promise in Clinical Trials
- Dennis Thompson HealthDay Reporter
- June 27, 2023
- Full Page
An experimental drug appears to outperform the trendy medications Wegovy and Ozempic for both weight loss and diabetes control, a pair of early clinical trials shows.
Retatrutide helped people with obesity drop about one-quarter of their starting weight, on average, duri...
Treatment-Resistant High Blood Pressure May Be More Common Than Thought
- Steven Reinberg HealthDay Reporter
- June 26, 2023
- Full Page
One in 10 people with high blood pressure suffer from a treatment-resistant type of hypertension, yet these patients aren't always getting the right medication, a new study finds.
"Apparent resistant hypertension [aRH] is more common than many would anticipate," said res...
What Medications Are Used to Treat Alzheimer's?
- Sue Benzuly, RN HealthDay Reporter
- June 21, 2023
- Full Page
While there is no cure for Alzheimer's, there are medications that can help ease symptoms and slow the progression of this devastating disease.
Alzheimer's disease is the most common type of dementia, affecting over 5.8 million Americans, according to the
Pfizer Warns of Looming Shortage of Long-Acting Penicillin for Kids
- Cara Murez HealthDay Reporter
- June 16, 2023
- Full Page
Pfizer Inc. warned doctors this week of an impending shortage of Bicillin, its long-acting, injectable form of penicillin.
The medication is not commonly used for children because alternatives such as amoxicillin are preferred over the Bicillin shot, t
Chinese Company May Help Ease U.S. Shortage of Cancer Drug
- Cara Murez HealthDay Reporter
- June 5, 2023
- Full Page
With the United States facing a high number of drug shortages, a Chinese company may help to boost the supply of one in particular, the chemotherapy agent cisplatin.
The U.S. Food and Drug Administration is working with the Chinese drugmaker Qilu Pharmaceutical to i...